A recent study has demonstrated that AURKA could confer self-renewal capacity of competing away the binding of AXIN from β-catenin, inducing β-catenin stabilization and activating Wnt signaling in glioma-initiating cells [20]. The gene discussed is AURKA; the disease is glioma.